[go: up one dir, main page]

ATE71385T1 - Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten. - Google Patents

Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.

Info

Publication number
ATE71385T1
ATE71385T1 AT87901055T AT87901055T ATE71385T1 AT E71385 T1 ATE71385 T1 AT E71385T1 AT 87901055 T AT87901055 T AT 87901055T AT 87901055 T AT87901055 T AT 87901055T AT E71385 T1 ATE71385 T1 AT E71385T1
Authority
AT
Austria
Prior art keywords
medications
therapy
functional
pct
organic bases
Prior art date
Application number
AT87901055T
Other languages
English (en)
Inventor
Carlo Scolastico
Camillo Maria Franco G Palazzi
Original Assignee
S Team Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Team Srl filed Critical S Team Srl
Application granted granted Critical
Publication of ATE71385T1 publication Critical patent/ATE71385T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT87901055T 1986-02-12 1987-02-12 Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten. ATE71385T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT8619382A IT1213034B (it) 1986-02-12 1986-02-12 Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
EP87901055A EP0256069B1 (de) 1986-02-12 1987-02-12 Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten
PCT/EP1987/000068 WO1987005024A1 (en) 1986-02-12 1987-02-12 Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base

Publications (1)

Publication Number Publication Date
ATE71385T1 true ATE71385T1 (de) 1992-01-15

Family

ID=11157215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87901055T ATE71385T1 (de) 1986-02-12 1987-02-12 Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.

Country Status (19)

Country Link
US (1) US4950776A (de)
EP (1) EP0256069B1 (de)
JP (1) JPH0780775B2 (de)
KR (1) KR940011187B1 (de)
AT (1) ATE71385T1 (de)
AU (1) AU601403B2 (de)
CA (1) CA1291766C (de)
DE (1) DE3775854D1 (de)
DK (1) DK169339B1 (de)
FI (1) FI874450A (de)
HU (1) HU199148B (de)
IE (1) IE59283B1 (de)
IL (1) IL81549A0 (de)
IT (1) IT1213034B (de)
NO (1) NO874241L (de)
NZ (1) NZ219259A (de)
PH (1) PH24445A (de)
WO (1) WO1987005024A1 (de)
ZA (1) ZA871032B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348859A1 (de) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-Di-O-acyl glycero(DI)phosphat von L-carnitin und dessen Derivate, ein Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
IT1230140B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della serina, loro processo di preparazione e impiego in terapia umana
IT1231776B (it) * 1989-08-07 1991-12-21 Magis Farmaceutici Processo per preparare i derivati acetilati della l alfa glicerofosforil serina.
IT1254471B (it) * 1992-02-27 1995-09-25 Magis Farmaceutici Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
JP6195949B2 (ja) 2016-02-26 2017-09-13 株式会社リケン ピストンリング
CN108558937B (zh) * 2018-04-19 2019-05-24 厦门大学 一种L-α-甘油磷脂酰丝氨酸及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
DE3212387A1 (de) * 1982-04-02 1983-10-13 Bayer Ag, 5090 Leverkusen Glycerinphosphatide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4624852A (en) * 1983-05-16 1986-11-25 Massachusetts Institute Of Technology Process and composition for treating neurological disorders and aging
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
IT1199972B (it) * 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Also Published As

Publication number Publication date
IT8619382A0 (it) 1986-02-12
IE59283B1 (en) 1994-02-09
DK532087D0 (da) 1987-10-12
KR880700805A (ko) 1988-04-12
JPS63502893A (ja) 1988-10-27
NZ219259A (en) 1989-04-26
ZA871032B (en) 1987-08-04
CA1291766C (en) 1991-11-05
US4950776A (en) 1990-08-21
DE3775854D1 (de) 1992-02-20
IE870361L (en) 1987-08-12
EP0256069B1 (de) 1992-01-08
FI874450A0 (fi) 1987-10-09
NO874241L (no) 1987-12-09
FI874450A (fi) 1987-10-09
PH24445A (en) 1990-06-25
DK169339B1 (da) 1994-10-10
HUT47299A (en) 1989-02-28
HU199148B (en) 1990-01-29
IL81549A0 (en) 1987-09-16
DK532087A (da) 1987-10-12
JPH0780775B2 (ja) 1995-08-30
AU601403B2 (en) 1990-09-13
EP0256069A1 (de) 1988-02-24
NO874241D0 (no) 1987-10-09
KR940011187B1 (ko) 1994-11-26
AU7025087A (en) 1987-09-09
WO1987005024A1 (en) 1987-08-27
IT1213034B (it) 1989-12-07

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ATE84546T1 (de) Insulinabkoemmlinge und arzneimittel die diese enthalten.
GR861803B (en) Novel carbonic acid derivatives method for their preparation their use and medicine containing them
ATE71385T1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
DE3750235D1 (de) Behandlung von autoimmunen Krankheiten mit Immunoverstärkungssubstanzen.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
ATE172114T1 (de) Pharmazeutische zusammensetzung, die carbachol und andere cholinerge substanzen enthält
GB980436A (en) The acid salt composed of acetyl glutamic acid and n,n-dimethylaminoethanol-1 and preparation of same
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
EP0495998A4 (de)
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
DE3880066D1 (de) Optisch aktive fluessigkristallverbindungen und zusammensetzungen, die diese enthalten.
DE3877747D1 (de) Glasartige matrize zur verabreichung von heilmitteln.
ATE6124T1 (de) Arzneimittel zur lokalen behandlung des glaukoms.
DK0608648T3 (da) Højdoserede vitamin A-præparater
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.
NO950842L (no) Diarylpiperazinoacetamidforbindelser som antimuskariniske midler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee